GB0215775D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number: GB0215775D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical compounds; pharmaceutical; compounds
Prior art date: 2002-07-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GB0215775A

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Astex Technology Ltd

Original Assignee

Astex Technology Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-06

Filing date

2002-07-06

Publication date

2002-08-14

2002-07-06 Application filed by Astex Technology Ltd filed Critical Astex Technology Ltd

2002-07-06 Priority to GB0215775A priority Critical patent/GB0215775D0/en

2002-08-14 Publication of GB0215775D0 publication Critical patent/GB0215775D0/en

2003-07-04 Priority to PCT/GB2003/002905 priority patent/WO2004004730A2/fr

2003-07-04 Priority to AU2003242860A priority patent/AU2003242860A1/en

Status Ceased legal-status Critical Current

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
GB0215775A GB0215775D0 (en)	2002-07-06	2002-07-06	Pharmaceutical compounds
PCT/GB2003/002905 WO2004004730A2 (fr)	2002-07-06	2003-07-04	Composes pharmaceutiques
AU2003242860A AU2003242860A1 (en)	2002-07-06	2003-07-04	2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0215775A GB0215775D0 (en)	2002-07-06	2002-07-06	Pharmaceutical compounds

Publications (1)

Publication Number	Publication Date
GB0215775D0 true GB0215775D0 (en)	2002-08-14

Family

ID=9940040

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0215775A Ceased GB0215775D0 (en)	2002-07-06	2002-07-06	Pharmaceutical compounds

Country Status (3)

Country	Link
AU (1)	AU2003242860A1 (fr)
GB (1)	GB0215775D0 (fr)
WO (1)	WO2004004730A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2486187C (fr)	2002-05-23	2013-02-19	Cytopia Pty Ltd.	Inhibiteurs de la kinase
WO2005058876A1 (fr) *	2003-12-16	2005-06-30	Gpc Biotech Ag	Derives de la pyrazine utilises en tant que composes efficaces contre les maladies infectieuses
AU2005230847B2 (en) *	2004-03-31	2012-11-08	Exelixis, Inc.	Anaplastic lymphoma kinase modulators and methods of use
ATE458730T1 (de)	2004-04-13	2010-03-15	Icagen Inc	Polycyclische pyrazine als kaliumionenkanal- modulatoren
WO2006044826A2 (fr) *	2004-10-20	2006-04-27	Compass Pharmaceuticals Llc	Compositions et leur utilisation en tant qu'agents antitumoraux
GB0719644D0 (en) *	2007-10-05	2007-11-14	Cancer Rec Tech Ltd	Therapeutic compounds and their use
DE102008022788A1 (de) *	2008-05-08	2009-11-12	Süd-Chemie AG	2,6-Pyrazinverbrückte Carbenkomplexe
EP2417123A2 (fr) *	2009-04-06	2012-02-15	Agios Pharmaceuticals, Inc.	Compositions thérapeutiques et procédés d'utilisation associés
DK2427441T3 (en)	2009-05-04	2017-03-20	Agios Pharmaceuticals Inc	PKM2 Activators for use in the treatment of cancer
CA2944788C (fr)	2009-06-29	2023-08-22	Agios Pharmaceuticals, Inc.	Composes, et compositions associees, qui modulent la pyruvate kinase m2, et methodes de fabrication associees
EP2448581B1 (fr)	2009-06-29	2016-12-07	Agios Pharmaceuticals, Inc.	Compositions thérapeutiques et procédés d'utilisation associés
JP5837091B2 (ja)	2010-12-17	2015-12-24	アジオスファーマシューティカルズ，インコーポレイテッド	ピルビン酸キナーゼｍ２（ｐｋｍ２）調節剤としての新規ｎ−（４−（アゼチジン−１−カルボニル）フェニル）−（ヘテロ−）アリールスルホンアミド誘導体
JP6092118B2 (ja)	2010-12-21	2017-03-08	アジオスファーマシューティカルズ，インコーポレイテッド	ニ環式ｐｋｍ２活性化剤
TWI549947B (zh)	2010-12-29	2016-09-21	阿吉歐斯製藥公司	治療化合物及組成物
KR101873543B1 (ko)	2011-05-03	2018-07-02	아지오스 파마슈티컬스 아이엔씨.	치료에 사용하기 위한 피루베이트 키나아제 활성제
WO2012151440A1 (fr)	2011-05-03	2012-11-08	Agios Pharmaceuticals, Inc.	Procédés d'utilisation d'activateurs de pyruvate kinase
ES2634014T3 (es)	2013-01-30	2017-09-26	Bayer Pharma Aktiengesellschaft	Isotiazoles sustituidos con amino
WO2014139144A1 (fr)	2013-03-15	2014-09-18	Agios Pharmaceuticals, Inc.	Composés et compositions thérapeutiques
CN105985322A (zh) *	2015-03-03	2016-10-05	苏州翔实医药发展有限公司	氨基吡嗪化合物及其用途
DK3307271T3 (da)	2015-06-11	2023-10-09	Agios Pharmaceuticals Inc	Fremgangsmåder til anvendelse af pyruvatkinase-aktivatorer
CN112142716B (zh) *	2020-10-29	2021-08-31	山东新时代药业有限公司	一种5元杂芳基取代的吡嗪衍生物及其应用
WO2024050374A2 (fr) *	2022-09-02	2024-03-07	Miralogx Llc	Composés anti-inflammatoires, compositions pharmaceutiques et méthodes de traitement de l'hémochromatose et d'autres troubles

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0254259A3 (fr) *	1986-07-21	1989-11-23	Otsuka Pharmaceutical Factory, Inc.	Dérivés de p-aminophénols
GR900100380A (el) *	1989-05-20	1991-10-10	Fisons Plc	Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
US6506747B1 (en) *	1998-06-05	2003-01-14	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
SE9903894D0 (sv) *	1999-10-28	1999-10-28	New Pharma Research Ab	Novel compounds
SE9904108D0 (sv) *	1999-11-15	1999-11-15	New Pharma Research Ab	Nya föreningar
PT1330452E (pt) *	2000-09-20	2009-01-22	Ortho Mcneil Pharm Inc	Derivados de pirazina como moduladores de tirosina-cinases
PL361690A1 (en) *	2000-11-20	2004-10-04	Biovitrum Ab	Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
WO2002060492A1 (fr) *	2001-01-30	2002-08-08	Cytopia Pty Ltd	Procedes d'inhibition de kinases
AU2002342051B2 (en) *	2001-10-12	2009-06-11	Irm Llc	Kinase inhibitor scaffolds and methods for their preparation
GB0124939D0 (en) *	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds

2002
- 2002-07-06 GB GB0215775A patent/GB0215775D0/en not_active Ceased
2003
- 2003-07-04 AU AU2003242860A patent/AU2003242860A1/en not_active Abandoned
- 2003-07-04 WO PCT/GB2003/002905 patent/WO2004004730A2/fr not_active Ceased

Also Published As

Publication number	Publication date
AU2003242860A1 (en)	2004-01-23
WO2004004730A2 (fr)	2004-01-15
AU2003242860A8 (en)	2004-01-23
WO2004004730A3 (fr)	2004-04-29

Publication	Publication Date	Title
GB0218625D0 (en)	2002-09-18	Pharmaceutical compounds
EG27104A (en)	2015-06-09	Pharmaceutical compounds
GB0217225D0 (en)	2002-09-04	Medicinal compounds
GB0225540D0 (en)	2002-12-11	Medicinal compounds
GB0204719D0 (en)	2002-04-17	Medicinal compounds
GB0225535D0 (en)	2002-12-11	Medicinal compounds
GB0220730D0 (en)	2002-10-16	Medicinal compounds
GB0225030D0 (en)	2002-12-04	Medicinal compounds
GB0315657D0 (en)	2003-08-13	Pharmaceutical compounds
GB0215775D0 (en)	2002-08-14	Pharmaceutical compounds
GB0308511D0 (en)	2003-05-21	Pharmaceutical compounds
GB0317315D0 (en)	2003-08-27	Pharmaceutical compounds
GB0313766D0 (en)	2003-07-23	Pharmaceutical compounds
GB0206505D0 (en)	2002-05-01	Pharmaceutical combination
GB0301736D0 (en)	2003-02-26	Pharmaceutical compounds
PL373409A1 (en)	2005-08-22	Pharmaceutical combination
GB0204392D0 (en)	2002-04-10	Pharmaceutical compound
GB0329617D0 (en)	2004-01-28	Pharmaceutical compounds
GB0310361D0 (en)	2003-06-11	Pharmaceutical compound
GB0230153D0 (en)	2003-02-05	Pharmaceutical compounds
GB0215939D0 (en)	2002-08-21	Pharmaceutical compounds
GB0215180D0 (en)	2002-08-07	Pharmaceutical compounds
GB0208248D0 (en)	2002-05-22	Pharmaceutical compounds
GB0204391D0 (en)	2002-04-10	Pharmaceutical compound
GB0212459D0 (en)	2002-07-10	Pharmaceutical compound

Legal Events

Date	Code	Title	Description
2003-10-01	AT	Applications terminated before publication under section 16(1)